Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. With 66% stake, ...
Seven S&P 500 high-yield 'safer' dividend stocks—like Ford, AT&T, and VICI—offer strong payouts supported by free cash flow ...
Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...
What actually happened: the S&P 500's EPS for calendar 2000 rose just 3.8% higher than a year earlier - 15.2 percentage points lower than originally projected. A similarly large slip would transform ...
The current consensus expectation (according to Wall Street firm CFRA) is that the S&P 500's EPS in 2026 will be 14.1% higher than 2025's, double its 50-year annualized growth rate of 7.1%. If the EPS ...
AbbVie's Q1 2026 dividend increases 5.5% YOY, lagging both its past growth rates and the healthcare sector median. Learn more ...
A meaningful portion of AbbVie’s ABBV revenues comes from its oncology franchise. Initially anchored by blood cancer drugs ...
Zacks Investment Research on MSN
Is LLY's Ventyx deal another attempt at diversification beyond GLP-1?
Eli Lilly LLY has pursued a series of acquisitions since early 2025 to strengthen its pipeline and support long-term growth amid intensifying competition in the obesity space. While cardiometabolic ...
Pfizer PFE stock has declined almost 5% in a month, losing $7.3 billion in market capitalization. Shares dipped recently ...
Shares of Pfizer Inc. PFE rallied 1.71% to $25.58 Wednesday, on what proved to be an all-around poor trading session for the ...
Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback